Novartis International AG (Novartis International AG)
Current or Former Designated Public Official(s)
Lobbying activity
The following activities occurred for this specific Subject Matter Area.
Meeting (2-5)
The Irish Pharmaceutical Healthcare Association (IPHA) arranged four meetings in Brussels (one with experts from the Irish Perm Rep., three with MEPs) to discuss the General Pharmaceutical Legislation. Novartis participated in the meetings and was represented by Haseeb Ahmed, President Europe, Novartis, who provided a company perspective on the potential impact of the draft legislation.
Designated public officials lobbied
The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.